Related Experiment Video
Updated: May 30, 2026

08:26
Event-related Potentials During Target-response Tasks to Study Cognitive Processes of Upper Limb Use in Children with Unilateral Cerebral Palsy
Published on: January 11, 2016
Apolipoprotein E and functional motor severity in cerebral palsy
James A Blackman1, Matthew J Gurka, Yongde Bao
1Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Journal of Pediatric Rehabilitation Medicine
|July 28, 2011
Summary
The APOE ε4 allele may protect young children from severe cerebral palsy (CP). This genetic factor showed a trend towards reduced CP severity, especially with perinatal brain injury.
Area of Science:
- Neuroscience
- Genetics
- Developmental Pediatrics
Background:
- Cerebral palsy (CP) arises from non-progressive brain disturbances in early development.
- The APOE ε4 allele's role in brain injury outcomes differs between adults and young children.
- Previous research suggests APOE ε4 may be protective in very young populations.
Purpose of the Study:
- To investigate the hypothesis that the APOE ε4 allele is associated with reduced cerebral palsy severity.
- To explore the potential protective role of APOE ε4 in pediatric brain injury.
Main Methods:
- Genotyping of the APOE gene in 158 individuals with CP and their parents.
- Analysis of the association between APOE ε4 allele presence/number and CP severity.
- Family-based analysis using Transmission Disequilibrium Test (TDT) to assess genetic effects.
Main Results:
- 30% of CP subjects carried at least one APOE ε4 allele.
- A trend suggested individuals with an ε4 allele had lower CP severity (p=0.11).
- Higher ε4 allele count correlated with lower CP severity (p=0.12); perinatal brain injury significantly predicted lower severity (p<0.01).
Conclusions:
- The APOE ε4 allele may confer protection against severe cerebral palsy in children.
- Findings suggest a contrasting role of APOE ε4 in pediatric versus adult brain injury outcomes.
- Further research is warranted to confirm APOE ε4's protective effect in fetal/neonatal brain injury.

